Compugen studies COM-902 in combination with COM-701 for advanced malignancies in phase I July 16, 2021 No Comments
H3Mab-17 significantly reduces tumor growth in mouse model of colorectal adenocarcinoma July 16, 2021 No Comments
LAVA begins dosing in phase I/IIa study of LAVA-051 in hematological malignancies July 15, 2021 No Comments
Valo submits CTA for first-in-human study of PeptiCRAd-1 in melanoma, TNBC and NSCLC July 14, 2021 No Comments
Genocea initiates phase I/IIa study of neoantigen-targeted T cell therapy GEN-011 July 14, 2021 No Comments
Enrollment ongoing in phase II study of ISA-101b vaccine plus cemiplimab in HPV16 cervical cancer July 14, 2021 No Comments
RSS